AstraZeneca Admits of Blood Clots but in “Very Rare Cases”
NEW DELHI, Apr 30: Global pharmaceutical giant AstraZeneca has said its AZD1222 vaccine against Covid-19, which was made under licence in India as Covishield, could cause low platelet counts and formation of blood clots in “very rare” cases. AstraZeneca has accepted a link between the vaccine and Thrombosis with Thrombocytopenia Syndrome (TTS), a medical condition […]


